Autologous Stem Cell Technology
Blood & Organ Banks · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+61 732197978Website
www.asctech.com.auRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Autologous Stem Cell Technology
Since 2013, ASCT, in conjunction with Australian and International medical practitioners, has conducted over 1,000 stem cell treatments and this number continues to grow. The primary product in Autologous Multi-Lineage Multi-Potential Cells (AMPCs) is an autologous stem cell for therapeutic and research use. Currently, the company manufactures AMPC stem cells for medical therapies and scientific research for both local distribution and global exportation.Explore more
Popular SearchesAutologous Stem Cell TechnologyAutologous Stem Cell Technology Pty LtdSIC Code 28,283NAICS Code 32,325Show more
Autologous Stem Cell Technology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Autologous Stem Cell Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Autologous Stem Cell Technology launches new products
Website visits: Recent activity has been detected on your website
Click to see if Autologous Stem Cell Technology had a recent Job posting/layoffs
Autologous Stem Cell Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Autologous Stem Cell Technology has new funding data
Earning: See what the market has to say on Autologous Stem Cell Technology recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Autologous Stem Cell Technology
Check out if Autologous Stem Cell Technology is spiking on competitors!
Check if Autologous Stem Cell Technology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Autologous Stem Cell Technology
Find 2 more new buyers
Compare Similar Companies to Autologous Stem Cell Technology
Compare insights from companies similar to Autologous Stem Cell Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Autologous Stem Cell Technology is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Autologous Stem Cell Technology is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Autologous Stem Cell Technology.
Autologous Stem Cell Technology Tech Stack
A closer look at the technologies used by Autologous Stem Cell Technology
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Autologous Stem Cell Technology
Sign Up For FreeTo access detailed company insights
Since 2013, ASCT, in conjunction with Australian and International medical practitioners, has conducted over 1,000 stem cell treatments and this number continues to grow. The primary product in Autologous Multi-Lineage Multi-Potential Cells (AMPCs) is an autologous stem cell for therapeutic and research use. Currently, the company manufactures AMPC... Read More
